Roussot N, Kaderbhai C, Ghiringhelli F
Cancers (Basel). 2025; 17(5).
PMID: 40075753
PMC: 11898530.
DOI: 10.3390/cancers17050906.
Zielinska M, Ciazynska M, Sulejczak D, Rutkowski P, Czarnecka A
Biomolecules. 2025; 15(2).
PMID: 40001572
PMC: 11853485.
DOI: 10.3390/biom15020269.
Raposo C, Yan P, Chen A, Majidi S, Hiam-Galvez K, Satpathy A
bioRxiv. 2025; .
PMID: 39990338
PMC: 11844384.
DOI: 10.1101/2025.02.10.637523.
Dadey R, Cui J, Rajasundaram D, Yano H, Liu C, Cohen J
Immunohorizons. 2025; 9(4).
PMID: 39965167
PMC: 11841976.
DOI: 10.1093/immhor/vlae014.
Hargadon K, Goodloe 3rd T, Woodall 2nd S
Cancer Rep (Hoboken). 2025; 8(2):e70145.
PMID: 39930625
PMC: 11810983.
DOI: 10.1002/cnr2.70145.
Mechanisms of T-cell Depletion in Tumors and Advances in Clinical Research.
Su X, Zhang M, Zhu H, Cai J, Wang Z, Xu Y
Biol Proced Online. 2025; 27(1):5.
PMID: 39905296
PMC: 11792740.
DOI: 10.1186/s12575-025-00265-6.
Cellular plasticity and non-small cell lung cancer: role of T and NK cell immune evasion and acquisition of resistance to immunotherapies.
Mestiri S, Sami A, Sah N, El-Ella D, Khatoon S, Shafique K
Cancer Metastasis Rev. 2025; 44(1):27.
PMID: 39856479
DOI: 10.1007/s10555-025-10244-8.
Neoadjuvant immunotherapy for non-small cell lung cancer: Opportunities and challenges.
Hu J, Zhang J, Wan S, Zhang P
Chin Med J Pulm Crit Care Med. 2025; 2(4):224-239.
PMID: 39834585
PMC: 11742355.
DOI: 10.1016/j.pccm.2024.11.003.
Nr4a1 and Nr4a3 redundantly control clonal deletion and contribute to an anergy-like transcriptome in auto-reactive thymocytes to impose tolerance in mice.
Nielsen H, Yang L, Mueller J, Ritter A, Hiwa R, Proekt I
Nat Commun. 2025; 16(1):784.
PMID: 39824797
PMC: 11742425.
DOI: 10.1038/s41467-025-55839-5.
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach.
Lopez de Rodas M, Villalba-Esparza M, Sanmamed M, Chen L, Rimm D, Schalper K
Nat Rev Clin Oncol. 2025; 22(3):163-181.
PMID: 39820025
DOI: 10.1038/s41571-024-00984-x.
Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1.
Mok S, Liu H, Agac Cobanoglu D, Anang N, Mancuso J, Wherry E
Proc Natl Acad Sci U S A. 2025; 122(2):e2418985122.
PMID: 39786926
PMC: 11745370.
DOI: 10.1073/pnas.2418985122.
Precursors of exhausted T cells are pre-emptively formed in acute infection.
Chu T, Wu M, Hoellbacher B, de Almeida G, Wurmser C, Berner J
Nature. 2025; .
PMID: 39778709
DOI: 10.1038/s41586-024-08451-4.
Beyond first-line therapy: efficacy and safety outcomes of continuing immunotherapy in extensive stage small cell lung cancer after PD-L1 inhibitor progression.
Peng J, Zhai X, Liu X, Huang Z, Wang Y, Wu P
Transl Oncol. 2024; 52:102249.
PMID: 39709719
PMC: 11832948.
DOI: 10.1016/j.tranon.2024.102249.
Nutrient-driven histone code determines exhausted CD8 T cell fates.
Ma S, Dahabieh M, Mann T, Zhao S, McDonald B, Song W
Science. 2024; 387(6734):eadj3020.
PMID: 39666821
PMC: 11881194.
DOI: 10.1126/science.adj3020.
Overcoming Resistance Mechanisms to Melanoma Immunotherapy.
Zheng D, Bozym D, Tarantino G, Sullivan R, Liu D, Jenkins R
Am J Clin Dermatol. 2024; 26(1):77-96.
PMID: 39636504
DOI: 10.1007/s40257-024-00907-7.
Unveiling KLHL23 as a key immune regulator in hepatocellular carcinoma through integrated analysis.
Xu L, Li B, Liu Y, Hu Z, Dan Q, Xu B
Aging (Albany NY). 2024; 16(22):13608-13626.
PMID: 39636292
PMC: 11723656.
DOI: 10.18632/aging.206167.
Getting the right combination to break the epigenetic code.
Tolu S, Viny A, Amengual J, Pro B, Bates S
Nat Rev Clin Oncol. 2024; 22(2):117-133.
PMID: 39623073
DOI: 10.1038/s41571-024-00972-1.
Dietary Restriction Enhances CD8 T Cell Ketolysis to Limit Exhaustion and Boost Anti-Tumor Immunity.
Oswald B, DeCamp L, Longo J, Dahabieh M, Bunda N, Ma S
bioRxiv. 2024; .
PMID: 39605550
PMC: 11601469.
DOI: 10.1101/2024.11.14.621733.
Comprehensive single-cell aging atlas of healthy mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer.
Angarola B, Sharma S, Katiyar N, Kang H, Nehar-Belaid D, Park S
Nat Aging. 2024; 5(1):122-143.
PMID: 39587369
PMC: 11754115.
DOI: 10.1038/s43587-024-00751-8.
An updated review of small-molecule HPK1 kinase inhibitors (2016-present).
Duan Y, Guo Z, Zhong W, Chen J, Xu S, Liu J
Future Med Chem. 2024; 16(22):2431-2450.
PMID: 39582317
PMC: 11622775.
DOI: 10.1080/17568919.2024.2420630.